Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis

Pharmacogenetics

Volumn 7, Issue 1, 1997, Pages 73-82

  Woolhouse, Norman M ^a   Qureshi, M Mansoor ^a   Bastaki, Salim M A ^a   Patel, Mahendra ^a   Abdulrazzaq, Yousef ^a   Bayoumi, Riad A L ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

genotype; N acetyltransferase; pharmacogenetics; United Arab Emirates

Indexed keywords

ACYLTRANSFERASE;

ADOLESCENT; ARTICLE; ENZYME ACTIVITY; ETHNOLOGY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; MUTATION; NORMAL HUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; UNITED ARAB EMIRATES;

ALLELES; ARABS; ARYLAMINE N-ACETYLTRANSFERASE; BASE SEQUENCE; DNA PRIMERS; GENE FREQUENCY; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RESTRICTION MAPPING; UNITED ARAB EMIRATES;

EID: 8244250753     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199702000-00010     Document Type: Article

References (20)

1. Arias TD, Jorge LF, Griese EU, Inaha T, Eichelbaum M. Polymorphic N-acetyltransferase (NAT2) in Amerindian populations of Panama and Columbia: High frequencies of point mutation 857A, as found in allele S3/M3. Pharmacogenetics 1995: 3, 328-331.
2. Bastaki SMA, Abdulrazzaq Y, Patel M, Bayoumi RAL. Woodhouse NM. Distribution of polymorphic N-acetyltransferase (NAT2) phenotypes among U.A.E. nationals. Emirates Med J 1996: 14, 15-19.
3. Bell DA, Taylor JA, Butler MA, Stephens KA, Wiest J, Brubaker LH, Kadlubar FF, Lucier GW. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylalor allele common in African-Americans. Carcinogenesis 1993: 14, 1689-1692.
4. Blum M, Grant DM, McBride W, Heim M, Meyer UA. Human arylmine N-acetyltransferase genes: isolation, chromosomal localization. and functional expression. DNA Cell Biol 1990: 9, 192-203.
5. Blum M, Demierre A, Grant DM, Heim M, Meyer UA. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc Natl Acad Sci USA 1991: 88, 5237-5241.
6. Deguchi T, Mashimo M, Suzuki T. Correlation between acctylator phenotypes and genotypes of polymorphic N-acetyltransferase in human liver. J Biol Chem 1990: 265, 12757-12760.
7. El-Yazigi A, Chalehy K, Martin CR. Acetylator phenotypes of Saudi Arabians by a simplified caffeine metabolites test. J Clin Pharmacol 1989: 29, 246-250.
8. Evans DAP, N-Acetyltransferase. Pharmacol Ther 1989: 42, 157-234.
9. Grant DM, Tang BK, Kalow W. A simple test for acetylator phenotyping using caffeine. Br J Clin Pharmacol 1984: 17, 459-464.
10. Hein DW, Ferguson RJ, Doll MA, Rustan TD, Gray K. Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. Hum Mol Genet 1994: 3, 729-734.
11. Hickman D, Sim E. N-acetyltransferase polymorphism: comparison of phenotype and genotype in humans. Biochem Pharmacol 1991: 42, 1007-1014.
12. Hickman D, Risch A, Camilleri J, Sim E. Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants. Pharmacogenetics 1992: 2, 217-226.
13. Hickman D, Risch A, Buckle V, Spurr NK, Jeremiah SJ, McCarthy A, Sim E. Chromosomal localisation of human genes for arylamine N-acetyltransferase. Biochem J 1994: 297, 441-445.
14. Ilett KF, Chiswell GM, Spargo RM, Platt E, Minchin RF. Acetylation phenotype and genotype in aboriginal leprosy patients from the north-west region of Western Australia. Pharmacogenetics 1993:3, 264-269.
15. Lin HJ, Han C-Y, Lin BK, Hardy S. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, Blacks, Hispanics and Whites: application to metabolic epidemiology. Am J Hum Genet 1993: 52, 827-834.
16. Lin HJ, Han C-Y, Lin BK, Hardy S. Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics 1994: 4, 125-134.
17. Vatsis KP, Maretell KJ, Weber WW. Diverse point mutations in the human gene for polymorphic N-acelyltransferase. Proc Natl Acad Sci USA 1991: 88, 6333-6337.
18. Vatsis KP, Weber WW, Bell DA, Dupret JM, Evans DA, Grant DM, Hein DW, Lin HJ, Meyer UA, Relling MV, Sim E, Suzuki T, Yamazoe Y. Nomenclature for N-acetyltransferases. Pharmacogenetics 1995: 5, 1-17.
19. Weber WW, Hein DW. N-Acetylation pharmacogenetics. Pharmacol Rev 1985: 37, 25-79.
20. 759 T in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics 1997: 7, 83-84.